Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Jan 28, 2019 at 10:10 AM EST

Short Interest Spikes in a Couple Major Pharma Stocks

The January 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jan 28, 2019 at 8:30 AM EST

Short Sellers Back Off Major Biotechs

The January 15 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Jan 25, 2019 at 11:20 AM EST

How AbbVie Tripped Up in Q4

AbbVie shares retreated after it released disappointing fourth-quarter financial results before the markets opened on Friday.

Chris Lange | Jan 24, 2019 at 10:25 AM EST

Why the Bristol-Myers Incredible Earnings Beat Is Getting Grounded

Bristol-Myers Squibb reported better-than-expected quarterly results before the markets opened on Thursday.

Douglas A. McIntyre | Jan 23, 2019 at 6:25 AM EST

Number of Uninsured Americans Hits 4-Year High

In the fourth quarter of last year, the number of uninsured Americans reached the highest rate since 2014, according to…

Chris Lange | Jan 22, 2019 at 1:00 PM EST

Can Editas Survive After Losing Its CEO?

Editas Medicine shares were crushed on Tuesday after the company announced that its president and chief executive, Katrine Bosley, would…

Chris Lange | Jan 22, 2019 at 8:30 AM EST

Johnson & Johnson Earnings: When Good Enough Just Isn’t Good Enough

Johnson & Johnson released better-than-expected fourth-quarter financial results before the markets opened on Tuesday.

Chris Lange | Jan 18, 2019 at 11:06 AM EST

FDA Diabetes Treatment Vote to Determine the Fate of Lexicon Therapeutics?

Lexicon shares fell on Friday after the FDA voted to approve the firm’s type 1 diabetes treatment. Although the result…

Chris Lange | Jan 18, 2019 at 9:50 AM EST

Is Immunomedics Breast Cancer Treatment Doomed After This FDA Update?

Immunomedics shares were crushed on Friday after the firm received disappointing news from the FDA on its breast cancer treatment.

Chris Lange | Jan 17, 2019 at 12:00 PM EST

Is Spectrum Pharma Getting Enough for Its Hematology/Oncology Portfolio?

Spectrum Pharmaceuticals on Thursday after the firm announced that it would be selling its portfolio of seven FDA-approved hematology/oncology products…

Chris Lange | Jan 16, 2019 at 12:28 PM EST

Major Pharma Sees Fading Short Interest

The December 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jan 16, 2019 at 11:55 AM EST

Why CVS and Walmart Are Parting Ways

CVS shares dipped on Tuesday after the company announced that it would be parting ways with the megastore Walmart.

Chris Lange | Jan 16, 2019 at 11:50 AM EST

Where Does Aptinyx Go Next After Disappointing Midstage Results for Pain Treatment?

Aptinyx shares were absolutely crushed on Wednesday after the firm reported midstage results from its clinical study in patients with…

Chris Lange | Jan 15, 2019 at 10:00 AM EST

Why CVS and Walmart Are Parting Ways

CVS shares dipped on Tuesday after the company announced that it would be parting ways with the megastore Walmart.

Chris Lange | Jan 11, 2019 at 9:50 AM EST

Major Pharma Sees Fading Short Interest

The December 31 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 107 108 109 110 111 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Short Interest Spikes in a Couple Major Pharma Stocks

Short Sellers Back Off Major Biotechs

How AbbVie Tripped Up in Q4

Why the Bristol-Myers Incredible Earnings Beat Is Getting Grounded

Number of Uninsured Americans Hits 4-Year High

Can Editas Survive After Losing Its CEO?

Johnson & Johnson Earnings: When Good Enough Just Isn’t Good Enough

FDA Diabetes Treatment Vote to Determine the Fate of Lexicon Therapeutics?

Is Immunomedics Breast Cancer Treatment Doomed After This FDA Update?

Is Spectrum Pharma Getting Enough for Its Hematology/Oncology Portfolio?

Major Pharma Sees Fading Short Interest

Why CVS and Walmart Are Parting Ways

Where Does Aptinyx Go Next After Disappointing Midstage Results for Pain Treatment?

Why CVS and Walmart Are Parting Ways

Major Pharma Sees Fading Short Interest

Dan Ives’ Own ETF Is Up 27% YTD. The AI Revolution Trade Is Real.

Forget QQQ as the Same Company Sells the Same Nasdaq-100 for 17% Less

The Death Cross Is Lying: Why Wall Street Is Still Loading Up on Hershey and Vertex

Medicare Part B Just Crossed $200 a Month, Here's What It Means for Retirees

'You're Under the Illusion That You're Good at This, and You're Not': Dave Ramsey to 24-Year-Old With $30,000 in Gambling Debt

Want $5,000 a Year From $100K? This ETF Pays Nearly Double VYM’s Yield

Dan Ives’ Own ETF Is Up 27% YTD. The AI Revolution Trade Is Real.

Health and Healthcare Articles

All Health and Healthcare Articles

Short Interest Spikes in a Couple Major Pharma Stocks

Short Sellers Back Off Major Biotechs

How AbbVie Tripped Up in Q4

Why the Bristol-Myers Incredible Earnings Beat Is Getting Grounded

Number of Uninsured Americans Hits 4-Year High

Can Editas Survive After Losing Its CEO?

Johnson & Johnson Earnings: When Good Enough Just Isn’t Good Enough

FDA Diabetes Treatment Vote to Determine the Fate of Lexicon Therapeutics?

Is Immunomedics Breast Cancer Treatment Doomed After This FDA Update?

Is Spectrum Pharma Getting Enough for Its Hematology/Oncology Portfolio?

Major Pharma Sees Fading Short Interest

Why CVS and Walmart Are Parting Ways

Where Does Aptinyx Go Next After Disappointing Midstage Results for Pain Treatment?

Why CVS and Walmart Are Parting Ways

Major Pharma Sees Fading Short Interest

Dan Ives’ Own ETF Is Up 27% YTD. The AI Revolution Trade Is Real.

Forget QQQ as the Same Company Sells the Same Nasdaq-100 for 17% Less

The Death Cross Is Lying: Why Wall Street Is Still Loading Up on Hershey and Vertex

Featured Reads

Medicare Part B Just Crossed $200 a Month, Here's What It Means for Retirees

'You're Under the Illusion That You're Good at This, and You're Not': Dave Ramsey to 24-Year-Old With $30,000 in Gambling Debt